ReviewJournal of advanced research2026
Targeting the human gut microbiome: a comparative review of probiotics, prebiotics, synbiotics, and postbiotics.
Review in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- The Gut Microbiome-Endocrine Axis in Obesity: Mechanisms and Therapeutics.Journal of gastroenterology and hepatology · 2026Review
- Restoring Microbial Signaling: A Metabolite-Immune-Redox Framework for Postbiotic Host-Directed Interventions.Medical sciences (Basel, Switzerland) · 2026Review
- Hollow CuAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Bioactive Peptides-Probiotics Interactions: Implications for Microbial Function and Human Health.Foods (Basel, Switzerland) · 2026Review
- Postbiotics in Dermatology: A Literature Review of Emerging Topical Therapies for Acne, Rosacea, and Eczema.Cureus · 2026Review
- Article
- The Role and Mechanism of Gut Microbiota and Metabolites in Vascular Calcification.International journal of molecular sciences · 2026Review
- Remodeling mechanisms and intervention strategies of the oral mucosal immune barrier.Frontiers in immunology · 2026Review
- Nutritional management in bronchiectasis: A practical guide for clinicians.Therapeutic advances in respiratory diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe human gut microbiome plays a central role in regulating host health, serving as a core hub for systemic physiological interactions. Dysregulation of the gut microbiome is implicated in a wide spectrum of local and systemic diseases. Research has evolved from establishing associations to elucidating the mechanistic roles of gut microbes and developing targeted strategies for their modulation, with a growing emphasis on their bidirectional communication with other organ systems. AIM OF REVIEW: This review aims to synthesize current knowledge on the composition and function of the gut microbiome, its functional crosstalk with the host, and its integral role in both health and disease. A major focus is placed on critically evaluating the mechanisms, efficacy, and applications of key microbiome-directed interventions-probiotics, prebiotics, synbiotics, and postbiotics-in maintaining or restoring gut-centric ecological balance. KEY SCIENTIFIC CONCEPTS OF REVIEW: The gut microbiome acts as a dynamic microbial organ essential for digestion, immune maturation, and metabolic homeostasis. Dysbiosis, characterized by a loss of beneficial microbes and an overgrowth of potential pathogens, is a critical factor in the pathogenesis of gastrointestinal disorders, metabolic diseases, and other systemic conditions. The gut microbiome engages in continuous bidirectional communication with distant organs, including the oral cavity, lungs, skin, and urinary tract, via specific axes (e.g., gut-oral, gut-lung, gut-skin), thereby exerting widespread influence on host physiology. Probiotics, prebiotics, synbiotics, and postbiotics represent complementary strategies to counteract dysbiosis and reestablish gut ecological integrity, ranging from introducing live beneficial bacteria to utilizing inactivated microbial cells and their bioactive metabolites. Enhancing the translational potential of these interventions requires deeper mechanistic insights and robust clinical validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.